SITAGLIVAC GM 1/1000

Sitaglivac GM 1/1000 is a prescription oral anti-diabetic medication used for the effective management of Type 2 Diabetes Mellitus in adults. It is a triple-combination therapy containing Glimepiride, Sitagliptin, and Metformin Hydrochloride, designed to control blood glucose levels through multiple mechanisms.

This combination helps improve insulin secretion, reduce glucose production in the liver, and enhance the body’s response to insulin, making it suitable for patients who require stronger glycemic control when single or dual therapy is insufficient.

Composition:

• Glimepiride – 1 mg

• Sitagliptin – 50 mg

• Metformin Hydrochloride – 1000 mg
  
  Uses / Indications Sitaglivac GM 1/1000 is used for: Management of Type 2 Diabetes Mellitus Improving blood sugar control in adults Patients not adequately controlled with diet, exercise, or dual therapy Reducing fasting and post-meal blood glucose levels Supporting long-term glycemic control to help prevent diabetes-related complications